rss
Br J Ophthalmol 2007;91:1265-1268 doi:10.1136/bjo.2007.116897
  • World view

Microbial contamination of multi-use ophthalmic solutions in Kenya

  1. M M Nentwich1,
  2. K H M Kollmann2,
  3. J Meshack3,
  4. D R Ilako2,
  5. U C Schaller1
  1. 1
    Universitäts-Augenklinik, Ludwig-Maximilians-Universität, Munich, Germany
  2. 2
    University of Nairobi, Department of Ophthalmology, Nairobi, Kenya
  3. 3
    University of Nairobi, Department of Microbiology, Nairobi, Kenya
  1. Martin Nentwich, Universitäts-Augenklinik der Ludwig-Maximilians-Universität, München, Mathildenstrasse 8, 80336 München, Germany; martin.nentwich{at}med.uni-muenchen.de
  • Accepted 7 April 2007
  • Published Online First 2 May 2007

Abstract

Background/aims: Contaminated ophthalmic solutions represent a potential cause of avoidable ocular infection. This study aimed to determine the magnitude and pattern of microbial contamination of multi-dose ocular solutions at the Department of Ophthalmology, University of Nairobi, at the Kenyatta National Hospital, Kenya.

Methods: 101 vials were obtained for microbial examination after an average use of 2 weeks. The dropper tip and the residual eye drop were examined for contamination. The specimens were cultured, the number of colonies counted, the organisms identified and susceptibility testing to selected antimicrobial agents was done.

Results: Six (6%) of the 101 analysed vials were contaminated: 4/77 vials (5%) from a multi-user setting and 2/24 vials (8%) from a single user setting. Three contaminations (3/38, 8%) occurred in vials from the eye ward, another three (3/59, 5%) in vials from the outpatient clinic. Most bacteria identified belonged to the normal commensal flora of the eye. Isolated contaminants were micrococci (n = 2), Staphylococcus epidermidis, Haemophilus sp, Bacillus sp and a Gram negative rod. The dropper tip was more often contaminated (n = 6) than the residual solution (n = 1), and only one vial showed a contamination of both the drop and the tip.

Conclusion: Our data show a contamination rate of 6%, which is in the lower range of data published on the contamination of eye drops elsewhere (0.07% to 35.8%).

Footnotes

  • Competing interests: None declared.

  • Abbreviations:
    BHI

    brain heart infusion

This Article

  1. All Versions of this Article:
    1. bjo.2007.116897v1
    2. 91/10/1265 most recent

Services

  1. Request permissions

Responses

  1. Submit a response
  2. No responses published

Social bookmarking

Register for free content


Free sample
This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of BJO.
View free sample issue >>

Free archive
The full back archive is now available for BJO. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006, back to volume 1 issue 1.
Register to access the free archive >>

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.